XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Costs and expenses:    
General and administrative $ 5,422 $ 6,030
Research and development 6,351 4,036
(Gain) loss on fair value remeasurement of deferred purchase consideration   (230)
Loss (gain) on fair value remeasurement of contingent consideration 158 1,847
Total costs and expenses 11,931 11,683
Loss from operations (11,931) (11,683)
Other income (expense):    
Interest income 504 675
Interest expense (1,455) (1,474)
Grant income 1,075  
Other (expense) income, net   (1,973)
Total other income (expense) 124 (2,772)
Net loss $ (11,807) $ (14,455)
Net loss per share attributable to common stockholders-basic (in dollar per share) $ (4.20) $ (6.99)
Weighted average shares outstanding-basic (in shares) 2,813,210 2,069,186
Weighted average common shares outstanding -diluted (in shares) 2,813,210 2,069,186
Statement of Comprehensive Loss    
Net loss $ (11,807) $ (14,455)
Other comprehensive loss:    
Total comprehensive loss $ (11,807) $ (14,455)